Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Oct 21, 2016 $84.00 $84.02 $81.85 $82.28 1 032 400
Oct 20, 2016 $84.41 $85.62 $83.71 $84.20 1 167 800
Oct 19, 2016 $85.35 $86.43 $83.65 $84.32 747 300
Oct 18, 2016 $86.15 $87.34 $85.20 $85.40 1 036 300
Oct 17, 2016 $84.83 $85.60 $82.19 $85.45 1 398 900
Oct 14, 2016 $87.58 $88.67 $84.58 $85.04 1 234 400
Oct 13, 2016 $86.31 $88.46 $86.00 $86.87 1 914 000
Oct 12, 2016 $91.46 $92.20 $87.73 $87.95 1 013 400
Oct 11, 2016 $93.09 $93.66 $90.72 $91.67 1 094 100
Oct 10, 2016 $94.07 $94.98 $92.42 $93.55 661 000
Oct 07, 2016 $93.19 $93.92 $91.55 $93.51 863 700
Oct 06, 2016 $95.13 $95.77 $92.12 $92.63 1 230 400
Oct 05, 2016 $94.69 $96.55 $94.32 $95.92 864 900
Oct 04, 2016 $94.59 $95.27 $94.04 $95.13 799 700
Oct 03, 2016 $91.98 $94.49 $91.19 $94.34 1 119 800
Sep 30, 2016 $93.08 $93.33 $91.20 $92.52 1 463 600
Sep 29, 2016 $96.02 $96.17 $92.43 $92.78 1 040 300
Sep 28, 2016 $98.19 $98.19 $94.42 $96.03 1 189 700
Sep 27, 2016 $95.43 $97.19 $94.25 $97.05 1 180 800
Sep 26, 2016 $96.86 $97.52 $95.43 $95.87 823 800
Sep 23, 2016 $96.63 $99.71 $96.63 $97.40 810 600
Sep 22, 2016 $98.00 $98.94 $95.69 $97.45 1 049 600
Sep 21, 2016 $97.97 $99.97 $95.00 $97.57 1 305 300
Sep 20, 2016 $98.97 $99.40 $97.52 $97.95 926 700
Sep 19, 2016 $96.62 $101.27 $95.23 $98.11 2 102 800
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT